Although clinical and pre-clinical evidence has also been found that the Tau protein and Aβ plaques may be linked to AD cognitive symptoms (Roda et al. 2022), there is no direct link between the Aβ plaque burden and cognitive performance. Here, MAPT is linked to Alzheimer disease.